New Releases from NCBI BookshelfDurvalumab for maintenance treatment of unresectable non-small-cell lung cancer after platinum-based chemoradiation.​Durvalumab for maintenance treatment of unresectable non-small-cell lung cancer after platinum-based chemoradiation.